Correction to: Protective and therapeutic role of 2-carbacyclic phosphatidic acid in demyelinating disease

  • J Neuroinflammation. 2018 Mar 5;15(1):67. doi: 10.1186/s12974-018-1104-x.
Shinji Yamamoto  1 ,  Kota Yamashina  1 ,  Masaki Ishikawa  1 ,  Mari Gotoh  2 ,  Sosuke Yagishita  1 ,  Kensuke Iwasa  1 ,  Kei Maruyama  1 ,  Kimiko Murakami-Murofushi  2 ,  Keisuke Yoshikawa  3
Affiliations
  • 1. Department of Pharmacology, Faculty of Medicine, Saitama Medical University, 38 Moro-hongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
  • 2. Endowed Research Division of Human Welfare Sciences, Ochanomizu University, 2-1-1 Ohtsuka, Bunkyo-ku, Tokyo, 112-8610, Japan.
  • 3. Department of Pharmacology, Faculty of Medicine, Saitama Medical University, 38 Moro-hongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan. [email protected].
PMID: 29506553 DOI: 10.1186/s12974-018-1104-x
Abstract

After publication of the article [1], it was brought to our attention that an acknowledgement was missing from the original version.

Products